Effect of topical azithromycin on corneal innate immune responses

Zahra Sadrai, Amir R. Hajrasouliha, Sunil Chauhan, Daniel R. Saban, Mohammad H. Dastjerdi, Reza Dana

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

PURPOSE. To determine the effect of azithromycin (AZM) in a murine model of corneal inflammation. METHODS. The effect of topical AZM was studied in murine corneal inflammation. Corneal inflammation was induced by thermal cautery in BALB/c mice. Leukocyte infiltration at different time points was analyzed by flow cytometry. At set time points, real-time polymerase chain reaction was performed to quantify the expression of different inflammatory cytokine transcript in the cornea. Corneal samples were analyzed immunohistochemically for the expression of intercellular adhesion molecule-1 (ICAM-1). Corneal neovascularization (CNV) was induced by micropellet (VEGF-A) placement. Mice were then treated topically with either AZM or vehicle. CNV was evaluated morphometrically. RESULTS. Eyes receiving AZM showed a significant decrease in corneal infiltration compared with the vehicle-treated group. AZM also significantly decreased messenger RNA expression levels of interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α) and ICAM-1 in the cornea. There was no significant difference in CNV between the AZM- and vehicle-treated groups. CONCLUSIONS. After an inflammatory insult, topical AZM significantly reduced leukocyte infiltration into the cornea. This was further supported by an associated decrease in expression of IL-1β, TNF-α, and ICAM-1 in the cornea, indicating AZM may have a potential anti-inflammatory effect on corneal inflammation.

Original languageEnglish (US)
Pages (from-to)2525-2531
Number of pages7
JournalInvestigative Ophthalmology and Visual Science
Volume52
Issue number5
DOIs
StatePublished - Apr 1 2011
Externally publishedYes

Fingerprint

Azithromycin
Innate Immunity
Corneal Neovascularization
Cornea
Intercellular Adhesion Molecule-1
Inflammation
Interleukin-1
Leukocytes
Tumor Necrosis Factor-alpha
Cautery
Vascular Endothelial Growth Factor A
Real-Time Polymerase Chain Reaction
Flow Cytometry
Anti-Inflammatory Agents
Hot Temperature
Cytokines
Messenger RNA

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Cite this

Effect of topical azithromycin on corneal innate immune responses. / Sadrai, Zahra; Hajrasouliha, Amir R.; Chauhan, Sunil; Saban, Daniel R.; Dastjerdi, Mohammad H.; Dana, Reza.

In: Investigative Ophthalmology and Visual Science, Vol. 52, No. 5, 01.04.2011, p. 2525-2531.

Research output: Contribution to journalArticle

Sadrai, Zahra ; Hajrasouliha, Amir R. ; Chauhan, Sunil ; Saban, Daniel R. ; Dastjerdi, Mohammad H. ; Dana, Reza. / Effect of topical azithromycin on corneal innate immune responses. In: Investigative Ophthalmology and Visual Science. 2011 ; Vol. 52, No. 5. pp. 2525-2531.
@article{758d392c21b348b6b66de85cb50fd54e,
title = "Effect of topical azithromycin on corneal innate immune responses",
abstract = "PURPOSE. To determine the effect of azithromycin (AZM) in a murine model of corneal inflammation. METHODS. The effect of topical AZM was studied in murine corneal inflammation. Corneal inflammation was induced by thermal cautery in BALB/c mice. Leukocyte infiltration at different time points was analyzed by flow cytometry. At set time points, real-time polymerase chain reaction was performed to quantify the expression of different inflammatory cytokine transcript in the cornea. Corneal samples were analyzed immunohistochemically for the expression of intercellular adhesion molecule-1 (ICAM-1). Corneal neovascularization (CNV) was induced by micropellet (VEGF-A) placement. Mice were then treated topically with either AZM or vehicle. CNV was evaluated morphometrically. RESULTS. Eyes receiving AZM showed a significant decrease in corneal infiltration compared with the vehicle-treated group. AZM also significantly decreased messenger RNA expression levels of interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α) and ICAM-1 in the cornea. There was no significant difference in CNV between the AZM- and vehicle-treated groups. CONCLUSIONS. After an inflammatory insult, topical AZM significantly reduced leukocyte infiltration into the cornea. This was further supported by an associated decrease in expression of IL-1β, TNF-α, and ICAM-1 in the cornea, indicating AZM may have a potential anti-inflammatory effect on corneal inflammation.",
author = "Zahra Sadrai and Hajrasouliha, {Amir R.} and Sunil Chauhan and Saban, {Daniel R.} and Dastjerdi, {Mohammad H.} and Reza Dana",
year = "2011",
month = "4",
day = "1",
doi = "10.1167/iovs.10-5658",
language = "English (US)",
volume = "52",
pages = "2525--2531",
journal = "Investigative Ophthalmology and Visual Science",
issn = "0146-0404",
publisher = "Association for Research in Vision and Ophthalmology Inc.",
number = "5",

}

TY - JOUR

T1 - Effect of topical azithromycin on corneal innate immune responses

AU - Sadrai, Zahra

AU - Hajrasouliha, Amir R.

AU - Chauhan, Sunil

AU - Saban, Daniel R.

AU - Dastjerdi, Mohammad H.

AU - Dana, Reza

PY - 2011/4/1

Y1 - 2011/4/1

N2 - PURPOSE. To determine the effect of azithromycin (AZM) in a murine model of corneal inflammation. METHODS. The effect of topical AZM was studied in murine corneal inflammation. Corneal inflammation was induced by thermal cautery in BALB/c mice. Leukocyte infiltration at different time points was analyzed by flow cytometry. At set time points, real-time polymerase chain reaction was performed to quantify the expression of different inflammatory cytokine transcript in the cornea. Corneal samples were analyzed immunohistochemically for the expression of intercellular adhesion molecule-1 (ICAM-1). Corneal neovascularization (CNV) was induced by micropellet (VEGF-A) placement. Mice were then treated topically with either AZM or vehicle. CNV was evaluated morphometrically. RESULTS. Eyes receiving AZM showed a significant decrease in corneal infiltration compared with the vehicle-treated group. AZM also significantly decreased messenger RNA expression levels of interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α) and ICAM-1 in the cornea. There was no significant difference in CNV between the AZM- and vehicle-treated groups. CONCLUSIONS. After an inflammatory insult, topical AZM significantly reduced leukocyte infiltration into the cornea. This was further supported by an associated decrease in expression of IL-1β, TNF-α, and ICAM-1 in the cornea, indicating AZM may have a potential anti-inflammatory effect on corneal inflammation.

AB - PURPOSE. To determine the effect of azithromycin (AZM) in a murine model of corneal inflammation. METHODS. The effect of topical AZM was studied in murine corneal inflammation. Corneal inflammation was induced by thermal cautery in BALB/c mice. Leukocyte infiltration at different time points was analyzed by flow cytometry. At set time points, real-time polymerase chain reaction was performed to quantify the expression of different inflammatory cytokine transcript in the cornea. Corneal samples were analyzed immunohistochemically for the expression of intercellular adhesion molecule-1 (ICAM-1). Corneal neovascularization (CNV) was induced by micropellet (VEGF-A) placement. Mice were then treated topically with either AZM or vehicle. CNV was evaluated morphometrically. RESULTS. Eyes receiving AZM showed a significant decrease in corneal infiltration compared with the vehicle-treated group. AZM also significantly decreased messenger RNA expression levels of interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α) and ICAM-1 in the cornea. There was no significant difference in CNV between the AZM- and vehicle-treated groups. CONCLUSIONS. After an inflammatory insult, topical AZM significantly reduced leukocyte infiltration into the cornea. This was further supported by an associated decrease in expression of IL-1β, TNF-α, and ICAM-1 in the cornea, indicating AZM may have a potential anti-inflammatory effect on corneal inflammation.

UR - http://www.scopus.com/inward/record.url?scp=79956017597&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79956017597&partnerID=8YFLogxK

U2 - 10.1167/iovs.10-5658

DO - 10.1167/iovs.10-5658

M3 - Article

C2 - 21296809

AN - SCOPUS:79956017597

VL - 52

SP - 2525

EP - 2531

JO - Investigative Ophthalmology and Visual Science

JF - Investigative Ophthalmology and Visual Science

SN - 0146-0404

IS - 5

ER -